US › Healthcare

Iradimed Co (IRMD)

US · Healthcare · Medical Devices

$93.13+1.71%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$22.0M
Revenue YoY
+12.7%
Net profit
$5.8M
Profit YoY
+24.1%
EPS
$0.49
EPS estimate
$0.45
Net margin
26.5%

EPS came in at 0.49 against a street estimate of 0.45 — a beat of 8.9%.

Key statistics

Market cap
$1.17B
P/E
51.2
Forward P/E
41.2
P/B
11.39
Book value
$7.71
EPS (TTM)
$1.79
Dividend yield
0.85%
52-week high
$107.44
52-week low
$66.58
50-day MA
$94.35
200-day MA
$93.49
Beta
0.91

Analyst view

Analysts rate Iradimed Co a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $118.00.

Shareholding

Insiders
35.20%
Institutions
61.22%

Largest institutional holders

FundStake
BlackRock Inc7.57%
Vanguard Group Inc4.38%
Renaissance Technologies Corp3.45%
Copeland Capital Management, LLC2.81%
Vanguard Capital Management, LLC2.81%
Kayne Anderson Rudnick Investment Management LLC2.73%
Nine Ten Capital Management LLC2.62%
Geode Capital Management, LLC2.24%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Iradimed Co — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.